Investors Press Releases
Xybion Digital Inc. Press Releases
Powering Innovation and Digital Transformation
Manage project risks and implement solution on track and on budget.
View Project Management ServicesComputer systems validation, testing and compliance services.
View Computer System ValidationGet started with a free consultation on us. It’s easy and risk-free.
Xybion Digital Inc. Press Releases
Home › Xybion Digital Inc. Announces Date of Second Quarter Fiscal 2022 Earnings Release and Conference Call Details
PRINCETON, N.J., Nov 18, 2021 — Xybion Digital Inc. (XYBN:TSXV), a global, low-code SaaS company that enables digital transformation in highly regulated industries like Life Sciences today announced that it will release its financial results for the three months ended September 30, 2021 on November 22, 2021 after the market close. Management will host a conference call to discuss the financial results on November 23, 2021 at 8:30am Eastern Time.
Conference Call
Date: November 23, 2021
Time: 8:30am Eastern Time
Canada/USA TF: 1-800-319-4610
International Toll: +1-604-638-5340
A transcript of the call will be posted on the Company’s website at www.xybion.com within 72 hours of the call.
About Xybion Digital Inc.
Xybion is a global SaaS company that helps enterprise life sciences organizations accelerate new drug development into approved medicines that save lives and keep employees safe. We digitize drug research and development, laboratory testing, regulatory approvals, and pharmaceutical manufacturing on a single, unified cloud platform that is cost-effective, ready to deploy, and easy to use. Xybion has over 160 clients using its low-code software to accelerate timelines, improve compliance, expand capacity, minimize operating risks, and reduce expenses while keeping employees safe.
Learn more about Xybion at https://www.xybion.com/
For more information regarding Xybion Digital Inc., please contact
Pradip Banerjee
Chief Executive Officer
105 College Road East
Princeton, New Jersey 08540
We use cookies to improve your experience. By continuing to use our site, you accept our use of cookies. Privacy Policy and Terms of Use.
Cookie SettingsAccept